Senseonics, Incorporated

Manufacturer of long-term implantable continuous glucose monitoring systems

Verified

1 Cert

About Senseonics, Incorporated

Senseonics, Incorporated is a medical device manufacturer specializing in continuous glucose monitoring (CGM) technology for diabetes management. The company develops and commercializes the Eversense CGM System, which is marketed as the first and only long-term implantable CGM available to patients.

The Eversense system includes implantable sensors with varying durations, including versions designed to last up to 180 days and 365 days. The company has published clinical research supporting the accuracy and safety of its technology, including the ENHANCE Study evaluating the 365-day system and the PROMISE Study for the 180-day version.

As a medical device manufacturer, Senseonics operates as a B2B entity within the healthcare sector, producing technology that healthcare providers use to monitor patients with diabetes. The company maintains an active investor relations presence and holds patents related to its CGM technology.

Best For

Healthcare providers and health systems seeking to offer patients long-term implantable continuous glucose monitoring as an alternative to traditional external CGM devices. Organizations focused on diabetes care management programs that could benefit from extended-wear monitoring technology.

Key Strengths

Proprietary long-term implantable CGM technology with 365-day duration, differentiating from short-term external devices
Published clinical validation through peer-reviewed studies including ENHANCE and PROMISE trials
Focused product portfolio dedicated specifically to diabetes monitoring technology
Patent portfolio protecting core CGM technology innovations

Why Choose Senseonics, Incorporated

Organizations should consider Senseonics when seeking to provide patients with a long-term implantable CGM alternative that reduces the frequency of sensor replacements compared to external systems. The company's focus on extended-wear technology may appeal to providers looking to improve patient adherence and reduce burden associated with frequent sensor changes.

Engagement involves working with a specialized medical device manufacturer with clinical evidence supporting product accuracy and safety over extended monitoring periods.

Healthcare Focus

Senseonics operates exclusively in healthcare as a medical device manufacturer focused on diabetes management technology. The company serves endocrinologists, primary care providers, and health systems treating patients with diabetes requiring continuous glucose monitoring. Their implantable CGM technology addresses clinical needs in diabetes care delivery and patient monitoring.

Ideal Client Profile

Endocrinology practices, diabetes care centers, and health systems with established diabetes management programs seeking to offer patients extended-wear CGM technology. Organizations with the clinical infrastructure to perform sensor insertion and removal procedures, and patient populations who may benefit from reduced sensor replacement frequency.